Skip to content
10-Q

Quarterly Report

Clovis Oncology, Inc.

0001558370-22-012579

← back to feed
Filed
Aug 8, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2022 · Jul 29, 2022 144.48M sh
Shares Diluted Q2 2022 · Jun 30, 2022 144.04M sh
Shares Diluted Q2 2022 · Jun 30, 2022 141.14M sh
Shares Diluted Q2 2022 · Jun 30, 2021 108.48M sh
Shares Diluted Q2 2022 · Jun 30, 2021 106.38M sh
Capex Q2 2022 · Jun 30, 2022 $108K
Capex Q2 2022 · Jun 30, 2021 $154K
Operating Cash Flow Q2 2022 · Jun 30, 2022 −$93.62M
Operating Cash Flow Q2 2022 · Jun 30, 2021 −$108.65M
Long Term Debt Q2 2022 · Jun 30, 2022 $437.8M
Cash And Equivalents Q2 2022 · Jun 30, 2022 $94.58M
Cash And Equivalents Q2 2022 · Dec 31, 2021 $143.43M
Stockholders Equity Q2 2022 · Jun 30, 2022 −$367.7M
Stockholders Equity Q2 2022 · Mar 31, 2022 −$303.31M
Stockholders Equity Q2 2022 · Dec 31, 2021 −$278.84M
Stockholders Equity Q2 2022 · Jun 30, 2021 −$206.98M
Stockholders Equity Q2 2022 · Mar 31, 2021 −$221.04M
Stockholders Equity Q2 2022 · Dec 31, 2020 −$158.75M
Current Liabilities Q2 2022 · Jun 30, 2022 $121.27M
Current Liabilities Q2 2022 · Dec 31, 2021 $125.21M
Total Liabilities Q2 2022 · Jun 30, 2022 $760.55M
Total Liabilities Q2 2022 · Dec 31, 2021 $751.67M
Current Assets Q2 2022 · Jun 30, 2022 $142.28M
Current Assets Q2 2022 · Dec 31, 2021 $198.09M
Total Assets Q2 2022 · Jun 30, 2022 $392.86M
Total Assets Q2 2022 · Dec 31, 2021 $472.83M
Eps Diluted Q2 2022 · Jun 30, 2022 −$0.50
Eps Diluted Q2 2022 · Jun 30, 2022 −$0.93
Eps Diluted Q2 2022 · Jun 30, 2021 −$0.61
Eps Diluted Q2 2022 · Jun 30, 2021 −$1.25
Eps Basic Q2 2022 · Jun 30, 2022 −$0.50
Eps Basic Q2 2022 · Jun 30, 2022 −$0.93
Eps Basic Q2 2022 · Jun 30, 2021 −$0.61
Eps Basic Q2 2022 · Jun 30, 2021 −$1.25
Sga Expense Q2 2022 · Jun 30, 2022 $32.59M
Sga Expense Q2 2022 · Jun 30, 2022 $61.8M
Sga Expense Q2 2022 · Jun 30, 2021 $32.92M
Sga Expense Q2 2022 · Jun 30, 2021 $62.86M
Net Income Q2 2022 · Jun 30, 2022 −$71.33M
Net Income Q2 2022 · Jun 30, 2022 −$131.5M
Net Income Q2 2022 · Mar 31, 2022 −$60.17M
Net Income Q2 2022 · Jun 30, 2021 −$66.45M
Net Income Q2 2022 · Jun 30, 2021 −$132.73M
Net Income Q2 2022 · Mar 31, 2021 −$66.28M
Operating Income Q2 2022 · Jun 30, 2022 −$59.38M
Operating Income Q2 2022 · Jun 30, 2022 −$109.74M
Operating Income Q2 2022 · Jun 30, 2021 −$57.58M
Operating Income Q2 2022 · Jun 30, 2021 −$115.59M
Revenue Q2 2022 · Jun 30, 2022 $32.14M
Revenue Q2 2022 · Jun 30, 2022 $66.39M
Revenue Q2 2022 · Jun 30, 2021 $36.82M
Revenue Q2 2022 · Jun 30, 2021 $74.87M